异基因造血干细胞移植治疗伴TP53基因异常骨髓增生异常综合征/急性髓系白血病42例疗效分析

OBJECTIVE: TP53-abnormal MDS/acute myeloid leukemia（AML）patients' allogeneic hematopoietic stem cell transplantation（allo-HSCT）treatment's effectiveness and influencing factors should be studied. METHODS: 42 patients with TP53 gene status change MDS/AML who underwent allo-HSCT from 2014.8....

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2023
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119729/
https://www.ncbi.nlm.nih.gov/pubmed/37356984
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119729/
https://www.ncbi.nlm.nih.gov/pubmed/37356984
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.03.008

Ejemplares similares